SOM Biotech kończy proces rekrutacji w badaniu fazy IIb leczenia pląsawicy w chorobie Huntingtona

SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical […]
Prilenia planuje złożyć wniosek o pozwolenie na dopuszczenie do obrotu w UE dla pridopidyny w chorobie Huntingtona

Prilenia announced today that they plan to submit a Marketing Authorization Application in the EU for the use of Pridopidine in the treatment of Huntington’s Disease. According to Dr. Michael […]